Begin typing your search...
You Searched For "Slayback Pharma"
Dr Reddy's to acquire Slayback's eyedrop rights
The company has inked a licensing pact with the US-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025%
The company has inked a licensing pact with the US-based drug firm to acquire rights in Brimonidine Tartrate Ophthalmic Solution 0.025%